HOME PRODUCTS COMPANY CONTACT FAQ

Research Dictionary Pharma

Sign Up FREE or Login

N-methylbenzamide

RN given refers to parent cpd

Also Known As:

N-methylbenzamide hydrochloride

Networked: 10 relevant articles (1 outcomes, 3 trials/studies)

Relationship Network

Bio-Agent Context: Research Results

Organic Chemicals: 133

Experts

1.	Fujinaga, Masayuki: 3 articles (01/2020 - 09/2013)
2.	Xie, Lin: 3 articles (01/2020 - 09/2013)
3.	Zhang, Ming-Rong: 3 articles (01/2020 - 09/2013)
4.	Hatori, Akiko: 2 articles (10/2014 - 09/2013)
5.	Kumata, Katsushi: 2 articles (10/2014 - 09/2013)
6.	Yamasaki, Tomoteru: 2 articles (10/2014 - 09/2013)
7.	Yui, Joji: 2 articles (10/2014 - 09/2013)
8.	Gong, Chaochao: 1 article (11/2021)
9.	Huang, Jian: 1 article (11/2021)
10.	Liu, Yue: 1 article (11/2021)

Related Diseases

1.	Spinal Cord Injuries (Spinal Cord Injury) 10/01/2005 - "We tested the efficacy of the neuokinin-2 receptor antagonist M274773 ((S)-N-[2-(3,4-Dichlorophenyl)-4-[4-(2-oxoperhydro-pyrimidin-l-yl) piperidino]butyl]-N-methylbenzamide dihydrochloride) on neurogenic detrusor overactivity after spinal cord injury in rats. "
2.	Melanoma (Melanoma, Malignant) 10/15/2014 - "Here, we report the development of an oncoprotein-based PET imaging platform in melanomas for noninvasive visualization and quantification of mGlu1 with a novel mGlu1-specific radioprobe, 4-(18)F-fluoro-N-[4-[6-(isopropyl amino)pyrimidin-4-yl]-1,3-thiazol-2-yl]-N-methylbenzamide ((18)F-FITM). " 01/01/2020 - "Herein, we developed 2 new radiopharmaceuticals, 4-131I-iodo- and 4-211At-astato-N-[4-(6-(isopropylamino)pyridine-4-yl)-1,3-thiazol-2-yl]-N-methylbenzamide (131I-IITM and 211At-AITM), targeting the ectopic metabotropic glutamate receptor 1 (mGluR1) in melanomas for TRT studies. "
3.	Neoplasms (Cancer) 11/05/2021 - "2-((2-((3-(Acetamidomethyl)phenyl)amino)-5-fluoro-7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino)-N-methylbenzamide (16c) was selected for further bioactivity evaluations in vivo, including preliminary pharmacokinetic profiling in rats and toxicity assays in mice, and tumor growth inhibition studies in a xenograft tumor model. "
4.	Ischemia 09/01/2013 - "The aim of this study was to visualize the mGlu1 receptor and to monitor neuroprotective effects in a rat model of mild focal ischemia using positron emission tomography (PET) with N-[4-[6-(isopropylamino)pyrimidin-4-yl]-1,3-thiazol-2-yl]-4-[(11)C]methoxy-N-methylbenzamide ([(11)C]ITMM), a radiotracer for mGlu1. "
5.	Ulcer 05/01/1993 - "Cardiovascular activities of 3-[[[2-(3,4-dimethoxyphenyl)ethyl]carbamoyl]methyl]-amino-N- methylbenzamide (DQ-2511, CAS 104775-36-2), an anti-ulcer drug, were investigated in anesthetized dogs and conscious rats. " 05/01/1993 - "Cardiovascular properties of the new anti-ulcer drug 3-[[[2-(3,4-dimethoxyphenyl)ethyl]carbamoyl]methyl]-amino-N- methylbenzamide." 05/01/1993 - "Pharmacological properties of the anti-ulcer drug 3-[[[2-(3,4-dimethoxyphenyl)ethyl]carbamoyl] methyl]-amino-N-methylbenzamide (DQ-2511, CAS 104775-36-2) on the central and autonomic nervous systems, smooth muscle, gastrointestinal system, and other miscellaneous systems were investigated. " 05/01/1993 - "General pharmacological profile of the new anti-ulcer drug 3-[[[2-(3,4-dimethoxyphenyl)ethyl]carbamoyl]methyl]-amino-N -methylbenzamide."

Related Drugs and Biologics

1.	(S)- N- (2- (3,4- dichlorophenyl)- 4- (4- (2- oxoperhydro- pyrimidin- l- yl) piperidino)butyl)-N-methylbenzamide dihydrochloride
2.	Radiopharmaceuticals
3.	Neuroprotective Agents
4.	Metabotropic Glutamate Receptors (Metabotropic Glutamate Receptor)
5.	metabotropic glutamate receptor type 1
6.	pyridine
7.	Oncogene Proteins (Oncogene Protein)
8.	Illicit Drugs (Recreational Drugs)
9.	Heroin (Diamorphine)
10.	U-47700